M959-M971
Morphology Classification: Hodgkin and non-Hodgkin lymphoma
- M9590/3Malignant lymphoma, NOS, primary site (C84.5, C85.9)
- M9591/3Malignant lymphoma, non-Hodgkin, NOS, primary site
- M9592/3Lymphosarcoma NOS, malignant, primary site (C85.0)
- M9593/3Reticulosarcoma NOS, malignant, primary site (C83.3, C83.9)
- M9594/3Microglioma, malignant, primary site (C85.7)
- M9595/3Malignant lymphoma, diffuse NOS, primary site (C83.59)
- M9596/3Composite Hodgkin and non-Hodgkin lymphoma, malignant, primary site
- M9596/6Composite Hodgkin and non-Hodgkin lymphoma, malignant, metastatic site
- M9597/3Primary cutaneous follicle centre lymphoma, malignant, primary site
- M9597/6Primary cutaneous follicle centre lymphoma, malignant, metastatic site
- M9650/3Hodgkin lymphoma, NOS, malignant, primary site
- M9651/3Hodgkin lymphoma, lymphocyte-rich, malignant, primary site
- M9651/6Hodgkin lymphoma, lymphocyte-rich, malignant, metastatic site
- M9652/3Hodgkin lymphoma, mixed cellularity, NOS, malignant, primary site
- M9653/3Hodgkin lymphoma, lymphocyte depletion, NOS, malignant, primary site
- M9654/3Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis, malignant, primary site
- M9655/3Hodgkin lymphoma, lymphocyte depletion, reticular, malignant, primary site
- M9657/3Hodgkin's disease, lymphocytic predominance NOS, malignant, primary site (C81.0)
- M9658/3Hodgkin's disease, lymphocytic predominance, diffuse, malignant, primary site (C81.0)
- M9659/3Hodgkin's lymphoma, lymphocyte predominance, nodular (C81.0)
- M9660/3Hodgkin's paragranuloma NOS, malignant, primary site (C81.7)
- M9661/3Hodgkin's granuloma (C81.7)
- M9662/3Hodgkin's sarcoma (C81.7)
- M9663/3Hodgkin's lymphoma, nodular sclerosis, NOS
- M9664/3Hodgkin's lymphoma, nodular sclerosis, cellular phase (C81.1)
- M9665/3Hodgkin's disease, nodular sclerosis, lymphocytic predominance (C81.1)
- M9666/3Hodgkin's disease, nodular sclerosis, mixed cellularity, malignant, primary site (C81.1)
- M9667/3Hodgkin's lymphoma, nodular sclerosis, lymphocytic depletion (C81.1)
- M9670/3Malignant lymphoma, small lymphocytic, NOS (C83.0)
- M9671/3Malignant lymphoma, lymphoplasmacytic (C83.8)
- M9672/3Malignant lymphoma, small cleaved cell, diffuse, primary site (C83.1)
- M9673/3Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse (C83.8)
- M9674/3Malignant lymphoma, centrocytic, primary site (C83.8)
- M9675/3Malignant lymphoma, mixed small and large cell, diffuse (C83.2)
- M9676/3Malignant lymphoma, centroblastic-centrocytic, diffuse, primary site (C83.8)
- M9677/3Malignant lymphomatous polyposis, primary site (C83.8)
- M9678/3Primary effusion lymphoma, malignant, primary site
- M9678/6Primary effusion lymphoma, malignant, metastatic site
- M9679/3Mediastinal large B-cell lymphoma, malignant, primary site (C38.3)
- M9679/6Mediastinal large B-cell lymphoma, malignant, metastatic site
- M9680/3Malignant lymphoma, large B-cell, diffuse, NOS (C83.3)
- M9681/3Malignant lymphoma, large cell, cleaved, diffuse, primary site (C83.3)
- M9682/3Malignant lymphoma, large cell, noncleaved, diffuse, primary site (C83.3)
- M9683/3Malignant lymphoma, centroblastic, diffuse, primary site (C83.8)
- M9684/3Malignant lymphoma, immunoblastic, NOS (C83.4)
- M9685/3Malignant lymphoma, lymphoblastic, primary site (C83.5)
- M9686/3Malignant lymphoma, small cell, noncleaved, diffuse, primary site (C83.0, C83.6)
- M9687/3Burkitt lymphoma, NOS (C83.7)
- M9688/3T-cell/histiocyte rich large B-cell lymhoma, malignant, primary site
- M9688/6T-cell/histiocyte rich large B-cell lymhoma, malignant, metastatic site
- M9689/3Splenic marginal zone B-cell lymphoma, malignant, primary site
- M9689/6Splenic marginal zone B-cell lymphoma, malignant, metastatic site
- M9690/3Malignant lymphoma, follicular NOS (C82.9)
- M9691/3Malignant lymphoma, mixed small cleaved and large cell, follicular (C82.1)
- M9692/3Malignant lymphoma, centroblastic-centrocytic, follicular, primary site (C82.8)
- M9693/3Malignant lymphoma, lymphocytic, well differentiated, nodular, primary site (C82.8)
- M9694/3Malignant lymphoma, lymphocytic, intermediate differentiation, nodular, primary site (C82.8)
- M9695/3Malignant lymphoma, small cleaved cell, follicular (C82.0)
- M9696/3Malignant lymphoma, lymphocytic, poorly differentiated, nodular, primary site (C82.8)
- M9697/3Malignant lymphoma, centroblastic, follicular, primary site (C82.8)
- M9698/3Malignant lymphoma, large cell, follicular NOS (C82.2)
- M9699/3Marginal zone B-cell lymphoma, NOS, malignant, primary site
- M9699/6Marginal zone B-cell lymphoma, NOS, malignant, metastatic site
- M9700/3Mycosis fungoides (C84.0)
- M9701/3Sezary syndrome (C84,1)
- M9702/3Peripheral T-cell lymphoma, NOS (C84.4)
- M9703/3T-zone lymphoma, malignant, primary site (C84.2)
- M9704/3Lymphoepithelioid lymphoma, malignant, primary site (C84.3)
- M9705/3Peripheral T-cell lymphoma, AILD (angioimmunoblastic lymphadenopathy with dysproteinaemia) (C84.4)
- M9706/3Peripheral T-cell lymphoma, pleomorphic small cell, malignant, primary site (C84.4)
- M9707/3Peripheral T-cell lymphoma, pleomorphic medium and large cell, malignant, primary site (C84.4)
- M9708/3Subcutaneous panniculitis-like T-cell lymphoma, malignant, primary site
- M9708/6Subcutaneous panniculitis-like T-cell lymphoma, malignant, metastatic site
- M9709/3Cutaneous lymphoma (C84.5)
- M9711/3Monocytoid B-cell lymphoma, malignant, primary site (C85.7)
- M9712/3Intravascular large B-cell lymphoma, malignant, primary site (C49.9)
- M9712/6Intravascular large B-cell lymphoma, malignant, metastatic site
- M9713/3Angiocentric T-cell lymphoma, malignant, primary site (C84.7)
- M9714/3Llarge cell (Ki 1+) lymphoma (C85.7)
- M9716/3Hepatosplenic T-cell lymphoma, malignant, primary site
- M9716/6Hepatosplenic T-cell lymphoma, malignant, metastatic site
- M9717/3Intestinal T-cell lymphoma, malignant, primary site
- M9717/6Intestinal T-cell lymphoma, malignant, metastatic site
- M9718/3Primary cutaneous CD30+ T-cell lymphoproliferative disorder, malignant, primary site (C44.-)
- M9718/6Primary cutaneous CD30+ T-cell lymphoproliferative disorder, malignant, metastatic site
- M9719/3NK/T-cell lymphoma, nasal and nasal-type, malignant, primary site
- M9719/6NK/T-cell lymphoma, nasal and nasal-type, malignant, metastatic site